This is a routine administrative correction with no trading signal. Monitor for any future Form 4 filings that would indicate actual insider transactions by CEO Tao Fu.
Price Chart
Executive Summary
This is a purely administrative amendment (3/A) to a Form 3 initial beneficial ownership filing. The amendment corrects the reporting person's CIK number from the issuer's CIK to the individual's own CIK. No changes were made to the reported securities holdings of CEO Tao Fu, who continues to own 87,843 shares directly, 461,709 shares via three trusts, and options for 803,436 shares. This filing has no material impact on the company's financials or operations.
Key Facts
- Form 3/A amends the original Form 3 filed on August 4, 2026, solely to correct the reporting person's CIK number.
- No changes were made to Tao Fu's beneficial ownership of Attovia Therapeutics securities.
- Tao Fu directly owns 87,843 shares of common stock and indirectly owns 461,709 shares through three trusts.
- Tao Fu holds options to purchase 803,436 shares of common stock at exercise prices ranging from $1.58 to $4.92.
- The filing includes a limited power of attorney appointing Steven Chan as attorney-in-fact for Section 16 filings.
Financial Impact
No financial impact — administrative correction only.
Risk Factors
- No risks identified from this administrative filing.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3/A Filing (Primary) | 0001644888-26-000008 |
| Document: 0001644888-26-000008-index-headers.html | 0001644888-26-000008 |
| Document: 0001644888-26-000008-index.html | 0001644888-26-000008 |
| Document: 0001644888-26-000008.txt | 0001644888-26-000008 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 8, 2026 18d ago | 3/A | $16.21 | awaiting T+20 | — | $15.00 (−7.46%) |
Oct 8, 2026 18d ago | 3/A | $16.21 | awaiting T+20 | — | $15.00 (−7.46%) |
Sep 28, 2026 29d ago | Press Release | $18.16 $15.00 | ▼ −17.40% | ▼ −18.12% | $15.00 (−17.40%) |
Sep 2, 2026 7w ago | Press Release | $24.20 $17.14 | ▼ −29.17% | ▼ −28.06% | $15.00 (−38.02%) |
Aug 28, 2026 8w ago | 144 / CLUSTER | $21.40 $18.16 | ▼ −15.14% | ▼ −14.95% | $15.00 (−29.91%) |
Aug 13, 2026 10w ago | Insider Buy | $19.86 $24.52 | ▲ +23.46% | ▲ +25.46% | $15.00 (−24.47%) |
Aug 13, 2026 10w ago | Insider Cluster | $19.86 $24.52 | ▲ +23.46% | ▲ +25.46% | $15.00 (−24.47%) |
Aug 10, 2026 11w ago | Insider Cluster | $18.65 $22.86 | ▲ +22.57% | ▲ +23.63% | $15.00 (−19.57%) |
Aug 7, 2026 11w ago | Insider Cluster | $19.84 $23.66 | ▲ +19.25% | ▲ +20.17% | $15.00 (−24.40%) |
Aug 7, 2026 11w ago | Insider Cluster | $20.17 $25.55 | ▲ +26.67% | ▲ +27.07% | $15.00 (−25.63%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers